Condensed Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets
Cash	$ 11,602	$ 29,804
Other current assets	45,821	41,669
Total Current Assets	57,423	71,473
Non-current assets
Plant and equipment	2,359	2,689
Equity method investment	4,200,001	4,200,001
Total Non-Current Assets	4,202,360	4,202,690
Total Assets	4,259,783	4,274,163
Current Liabilities
Accounts payable	2,345,311	2,510,541
Federal relief loans – current portion	11,840	11,184
Notes payable	2,060,228	1,997,040
Convertible debt, net of unamortized discount of $191,847 and $200,769, respectively	5,734,682	5,356,624
Derivative liability	563,437	1,581,520
Total Current Liabilities	10,973,751	11,718,260
Non-Current Liabilities
Federal relief loans	150,000	150,000
Total Non-Current Liabilities	150,000	150,000
Total Liabilities	11,123,751	11,868,260
Stockholders’ Deficit
Preferred stock, $0.0001 par value, 100,000,000 and 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.
Common stock, $0.0001 par value; 5,000,000,000 and 1,500,000,000 shares authorized 806,872,547 and 710,872,547 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.	80,687	71,087
Additional paid-in-capital	62,639,001	61,333,014
Accumulated deficit	(69,583,656)	(68,998,198)
Total Stockholders’ Deficit	(6,863,968)	(7,594,097)
Total Liabilities and Stockholders’ Deficit	4,259,783	4,274,163
Related Party
Current Liabilities
Related party payables		7,832
Convertible debt – related party	$ 258,253	$ 253,519